Diabetic Peripheral Neuropathy
Conditions
Interventions
treatment group:Diazepam 0.5 mg t.i.d., plus Beraprost sodium 40 µg t.i.d.
experimental group:Mecobalamin 0.5 mg t.i.d., beraprost sodium 40 µg t.i.d., Compound Danshen Dripping Pills 10 pills t.i.d.
Sponsors
Huai'an First People's Hospital, Nanjing Medical University
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: (1) Meet the diagnostic criteria of both Western medicine and Traditional Chinese Medicine (TCM), aged between 50 and 75 years, with a diabetes mellitus duration of 3 to 12 years. 2: (2) Confirmed diagnosis of diabetic peripheral neuropathy for 3 to 8 years. 3: (3) Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1: (1) Presence of severe diabetes-related complications, such as severe heart failure, sequelae of stroke, etc. 2: (2) Patients with a known allergy to the drugs used in the study. 3: (3) Presence of peripheral neuropathy attributable to other causes (e.g., alcoholic neuropathy, or neuropathy due to immune disorders, malignancies, etc.). 4: (4) Patients with psychiatric disorders that preclude cooperation with the treatment, as well as those with poor compliance. 5: (5)Diabetic peripheral neuropathy in patients with intact sural nerve function 6: (6)Type 1 diabetic patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amplitude of sural nerve sensory nerve action potential; | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine syndrome score; | — |
Countries
China
Contacts
Public ContactSunchengmei
Huai'an First People's Hospital, Nanjing Medical University)
Outcome results
None listed